AIDS-related focal brain lesions in the era of highly active antiretroviral therapy

Neurology

Volumn 55, Issue 8, 2000, Pages 1194-1200

  Ammassari, Adriana ^a   Cingolani, A ^a   Pezzotti, P ^b   De Luca, A ^a   Murri, R ^a   Giancola, M L ^c   Larocca, L M ^a   Antinori, A ^c  

^a CATHOLIC UNIVERSITY   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPROTOZOAL AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAIN BIOPSY; BRAIN DISEASE; BRAIN LYMPHOMA; CONTINUING EDUCATION; DISEASE COURSE; ENCEPHALITIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUROLOGICAL COMPLICATION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; TOXOPLASMA GONDII; TOXOPLASMOSIS; VIRUS INFECTION;

EID: 0034711175     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.55.8.1194     Document Type: Article

References (33)

1. Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1995
2. Diagnosis of AIDS-related focal brain lesions: A decision-making analysis based on clinical and neuroradiological characteristics combined with polymerase chain reaction assay in cerebrospinal fluid
3. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection
4. Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection
5. Changing disease pattern in focal brain lesion-causing disorders in AIDS
6. Increasing incidence of primary brain lymphoma in the US
7. Trends in primary cerebral lymphoma
8. Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome
9. Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000?
10. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
11. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy
12. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
13. Diagnosis ofintracranial lymphoma in patients with AIDS: Value of 201 T1 single-photon emission computed tomography
14. Use of thallium-201 brain SPECT to differentiate cerebral lymphoma from Toxoplasma encephalitis in AIDS patients
15. Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS-related primary CNS lymphoma
16. PET scanning and the human immunodeficiency virus-positive patient
17. Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma
18. JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: Predictive value for progressive multifocal leukoencephalopathy
19. Cytomegalovirus infection of the central nervous system in patients with AIDS: Diagnosis by DNA amplification from cerebrospinal fluid
20. Herpes simplex virus infections of the central nervous system in human immunodeficiency virus-infected patients: Clinical management by polymerase chain reaction assay of cerebrospinal fluid
21. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
22. Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus type-1 (HIV-1) infection. Report of the American Academy of Neurology AIDS Task Force
23. Positive effects of combined antiretroviral therapy on CD4+ T-cell homeostasis and function in advanced HIV disease
24. Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons
25. Has the spectrum of AIDS-defining illnesses been changing since the introduction of new treatments and combination treatments?
26. Long-term remission of AIDS-related primary central nervous system lymphoma associated with highly active antiretroviral therapy
27. Treatment of AIDS-related primary central nervous system lymphoma with zidovudine, ganciclovir, and interleukin 2
28. HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy
29. Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir and saquinavir
30. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy
31. Time course of cerebrospinal fluid responses to antiretroviral therapy: Evidence for variable compartmentalization of infection